Tech Company Inital Public Offerings
Onconova Therapeutics IPO
On 7/25/2013, Onconova Therapeutics completed its IPO
Transaction Overview
Company Name
Announced On
7/25/2013
Transaction Type
IPO
Amount
$78,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
375 Pheasant Run
Newtown, PA 18940
USA
Newtown, PA 18940
USA
Phone
Website
Email Address
Overview
Onconova Therapeutics (NASDAQ: ONTX) will create novel solutions for oncology that unequivocally benefit patients, empower healthcare professionals and provide significant value and satisfaction to customers and shareholders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Fruchtman
Chief Financial Officer
Mark Guerin
Chief Medical Officer
Ric Woodman
VP - General Counsel
Avi Oler
VP - Product Management
Manoj Maniar
Browse more venture capital transactions:
Prev: 7/25/2013: CreatiVasc Medical venture capital transaction
Next: 7/25/2013: BigCommerce venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. All VC database entries reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs